A Trial to Evaluate the Long-term Safety and Tolerability of HRS-5965 in Patients With Primary IgA Nephropathy
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Primary IgA Nephropathy
Related studies linked through entity extraction aliases.
A Study of YKST02 in Participants With Primary IgA Nephropathy
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
A Study of SHR-2173 in Participants With Primary IgA Nephropathy
- Status
- RECRUITING
- Phase
- PHASE2
A Trial of HRS-5965 Capsule in Primary IgA Nephropathy
- Status
- RECRUITING
- Phase
- PHASE3
Evaluate the Efficacy and Safety of NTQ5082 Capsules in Patients With Primary IgA Nephropathy
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Replication of the NefIgArd Trial of TRF-budesonide in Primary IgAN
- Status
- COMPLETED
- Phase
- N/A
A Trial of HRS-5965 Tablets in Primary IgA Nephropathy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Efficacy and Safety of SHR-2010 Injection in the Treatment of Primary IgA Nephropathy
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Telitacicept for IgA Nephropathy (TELIGAN)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression
- Status
- RECRUITING
- Phase
- PHASE3
A Trial of HR19042 Capsule in Healthy Chinese Subjects
- Status
- COMPLETED
- Phase
- PHASE1
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
- Status
- RECRUITING
- Phase
- PHASE3
Efficacy and Safety in Patients With Primary IgA Nephropathy Who Have Completed Study Nef-301 (Nefigard-OLE)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of RC18 Administered Subcutaneously to Subjects With Primary IgA(Immunoglobulin A) Nephropathy
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate the Effectiveness and Safety of IONIS-FB-LRx, an Antisense Inhibitor of Complement Factor B, in Adult Participants With Primary IgA Nephropathy
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of Nefecon in Patients With Primary IgA (Immunoglobulin A) Nephropathy
- Status
- COMPLETED
- Phase
- PHASE3
Hydroxychloroquine Sulfate Alleviates Persistent Proteinuria in IgA Nephropathy
- Status
- UNKNOWN
- Phase
- PHASE4
Integrative Medicine of IgA Nephropathy
- Status
- UNKNOWN
- Phase
- NA
Hydroxychloroquine Sulfate for Reduction of Proteinuria in Patients With IgA Nephropathy: a Self- Controlled Study
- Status
- COMPLETED
- Phase
- PHASE4
The Effect of Nefecon® in Patients With Primary IgA Nephropathy at Risk of Developing End-stage Renal Disease
- Status
- COMPLETED
- Phase
- PHASE2